Skip to main content

Published locations for FDA approves first oral somatostatin analog for acromegaly

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves first oral somatostatin analog for acromegaly

User login

  • Reset your password
  • /content/fda-approves-first-oral-somatostatin-analog-acromegaly
  • /familypracticenews/article/224662/pituitary-thyroid-adrenal-disorders/fda-approves-first-oral
  • /internalmedicinenews/article/224662/pituitary-thyroid-adrenal-disorders/fda-approves-first-oral
  • /clinicalendocrinologynews/article/224662/pituitary-thyroid-adrenal-disorders/fda-approves-first-oral
  • /endocrinology/article/224662/pituitary-thyroid-adrenal-disorders/fda-approves-first-oral
  • /internalmedicine/article/224662/pituitary-thyroid-adrenal-disorders/fda-approves-first-oral
  • /familymedicine/article/224662/pituitary-thyroid-adrenal-disorders/fda-approves-first-oral